ASTH Maintained by Freedom Capital Markets -- Price Target Remains $50
· gurufocus.com
Astrana Health Inc (ASTH) Analyst Rating Update On October 1, 2026, Freedom Capital Markets analyst Gene Mannheimer maintained a Buy rating for Astrana Healt
Astrana Health Inc ASTH Analyst Rating Update
On October 1, 2026, Freedom Capital Markets analyst Gene Mannheimer maintained a Buy rating for Astrana Health (A...